Prediction of conversion from paroxysmal to permanent atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 2, 2007, Pages 243-252

  Budeus, Marco ^a   Felix, Oliver ^b   Hennersdorf, Marcus ^b   Wieneke, Heinrich ^a   Erbel, Raimund ^a   Sack, Stefan ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chemoreflexsensitivity; P wave signal averaged ECG; Paroxysmal atrial fibrillation; Permanent atrial fibrillation

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN BREATHING; OXYGEN TENSION; P WAVE; RISK ASSESSMENT; SINUS RHYTHM;

AGED; ALGORITHMS; ATRIAL FIBRILLATION; CHEMORECEPTORS; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REFLEX; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33847373441     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00656.x     Document Type: Article

References (32)

1. Kannel WB, Abbott RD, Savage DD, Mc Namara PM. Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med 1982; 306:1018-1022.
2. Wolf PA, Abbott RD, Kannel WB, Savage DD. Atrial fibrillation as an independent risk factor of stroke: The Framingham Study. Stroke 1991; 22:983-988.
3. Peterson P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986; 17:622-626.
4. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation: A population-based study over three decades. N Engl J Med 1987; 317:669-674.
5. Coumel P. Paroxysmal atrial fibrillation: A disorder of autonomic tone? Eur Heart J 1994; 15(Suppl. A):9-16.
6. Yamaguchi I, Kurihara T, Maeda H, Endoh B, Niho K, Tanaka K, Kuga K, et al. Efficacy of β-blockade for prevention of paroxysmal atrial fibrillation evaluation by baroreflexsensitivity. Eur Heart J 1993; 14(Suppl.):293.
7. Zipes DP, Mihliek MJ, Robbins GT. Effects of selective vagal or stellate ganglion on atrial refractoriness. Cardiovasc Res 1974; 8:647-655.
8. Raitt MH, Kusumoto W, Giraud GD, McAnulty JH. Electrophysiologic predictors of the recurrence of persistent atrial fibrillation within 30 days of cardioversion. Am J Cardiol 2004; 93:107-110.
9. Budeus M, Hennersdorf M, Wieneke H, Sack S, Erbel R, Perings C. P wave signal averaged ECG and chemoreflexsensitivity in paroxysmal atrial fibrillation. Int J Cardiol 2005; 100:317-324.
10. Budeus M, Hennersdorf M, Röhlen S, Schnitzler S, Felix O, Reimer K, Feindt P, et al. Predicting of atrial fibrillation after coronary bypass grafting: The role of chemoreflexsensitivity and P wave signal averaged ECG. Int J Cardiol 2006; 106:67-74.
11. Budeus M, Perings C, Wieneke H, Erbel R. Prediction of recurrence of atrial fibrillation after successful cardioversion with chemoreflexsensitivity and P wave signal averaged ECG: A 12 months follow up of 118 patients. Europace 2005; 7(Suppl.):133.
12. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation. Europace 2006; 8:651-745; Eur Heart J 2006; 27:1979-2030; J Am Coll Cardiol 2006; 48:854-906; Circulation 2006; 114:257-354.
13. Aspromonte N, Auruti A, Ceci V. Efficacy of class Ic antiarrhythmic drugs predicted by P wave signal averaged ECG in patients with paroxysmal atrial fibrillation. J Amb Monitoring 1994; 7:115-119.
14. Hennersdorf MG, Perings Ch, Niebch V, Hillebrandt SV, Ester EG Strauer BE. Chemoreflexsensitivity in patients with survived sudden cardiac arrest and prior myocardial infarction. Pacing Clin Electrophysiol 2000; 23:457-462.
15. Spain MG, Smith MD, Grayburn PA, Harlamert EA, DeMaria AN. Quantitative assessment of mitral regurgitation by color Doppler flow imaging: Angiographic and hemodynamic correlations. J Am Coll Cardiol 1989; 13:585-590.
16. Abe Y, Fukunami M, Yamada T, Ohmori M, Shimonagata T, Kumagai K, Kim J, et al. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal averaged electrocardiography. A prospective study. Circulation 1997; 96:2612-2616.
17. Koide Y, Yotsukura M, Sakata K, Yoshino H, Ishikawa K. Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation. Clin Cardiol 2002; 25:69-75.
18. Kalman JM, Munawar M, Howes LG, Louis WJ, Buxton BF, Gutteridge G, Tonkin AM. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995; 60:1709-1715.
19. Frost L, Molgaard H, Christiansen EH, Jacobsen CJ, Allermand H, Thomsen PEB. Low vagal tone and supraventricular ectopic activity predict atrial fibrillation and flutter after coronary artery bypass grafting. Eur Heart J 1995; 16:825-831.
20. Tomita T, Takei M, Saikawa Y, Hanaoka T, Uchikawa SI, Tsutsui H, Aruga M, et al. Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol 2003; 14:559-564.
21. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Intern Pharmacodyn 1962; 140:183-188.
22. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92:1954-1968.
23. Lubinski A, Kempa M, Lewicka-Nowak E, Krolak T, Raczak G, Swiatecka G. Electrical atrial remodeling assessed by monophasic action potential and atrial refractoriness in patients with structural heart disease. Pacing Clin Electrophysiol 1998; 21:2440-2444.
24. Cosio FG, Palacios J, Vidal JM, Cocina EG, Gomez-Sanchez MA, Tamargo L. Electrophysiological studies in atrial fibrillation. Slow conduction of premature impulses: A possible manifestation of the background for reentry. Am J Cardiol 1983; 51:122-130.
25. Wozakowska-Kaplon B. Changes in left atrial size in patients with persistent atrial fibrillation: A prospective echocardiographic study with a 5-year follow-up period. Int J Cardiol 2005; 101:47-52.
26. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005; 149:489-496.
27. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999; 100:87-95.
28. Budeus M, Hennersdorf M, Perings Ch. The effect of antiarrhythmic medication on the variables of P wave signal averaged ECG among paroxysmal atrial fibrillation. Z Kardiol 2003; 92(Suppl.):II8.
29. Banasiak W, Telichowski A, Anker S, Fuglewicz A, Kalka D, Molenda W, Reczuch K, et al. Effects of Amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease. Am J Cardiol 1999; 83:112-114.
30. Budeus M, Hennersdorf M, Moysidis T, Perings Ch. Increase of the chemoreflexsensitivity by β-blocker therapy among adrenergically caused paroxysmal atrial fibrillation. Z Kardiol 2002; 91(Suppl.):V85.
31. Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, et al. Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005; 352:1861-1872.
32. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal atrial tachycardia. Circulation 1994; 89:224-227.